Definitive Healthcare Q1 revenue $59.2M (+18% YoY); net loss $15.6M

Definitive Healthcare Corp.

2023-Q1 EPS reported -$0.11 revenue$59,201,000

Revenue $59.2M (+18% YoY from $50.1M); net loss $15.6M vs $13.1M prior year.
Adjusted net income $9.2M, up from $7.7M; adjusted EBITDA $15.7M (26% of revenue).
Q2 2023 guidance: revenue $60.5-$61.5M; full-year 2023 rev $249-255M (+12-15% YoY).
Launched DefinitiveConnect for Salesforce integration and Atlas AI analytics suite.
Enterprise customers: 529 with >$100K ARR; won deals with pharma, hospital, and non-profit clients.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Definitive Healthcare Corp. reported the quarter ended March 31, 2023 results: revenue $59.2 million, net income ($15.6) million.

Period: the quarter ended March 31, 2023
Revenue: $59.2 million
Net income: ($15.6) million
Result: reported results

Exact text from the filing

--- EX-99 (EX-99.1) --- EX-99 Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2023 First quarter revenue grew 18% year-over-year to $59.2 million Framingham, MA (May 4, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare" or the "Company") (Nasdaq: DH), an industry leader in healthcare commercial intelligence,

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR

accession 0000950170-23-017910

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.